Humer Kristian 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jul 27, 2021
Insider Transaction Report
Form 4
Humer Kristian
CFO and CBO
Transactions
- Award
Stock Option (Right to Buy)
2021-07-26+360,000→ 360,000 totalExercise: $17.09Exp: 2031-07-26→ Common Stock (360,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.